Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CASTLE BIOSCIENCES INC Director's Dealing 2021

Oct 1, 2021

32601_dirs_2021-10-01_192f0bbf-03b8-42a7-bb2a-fc2781db9ba0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2021-09-30

Reporting Person: MAETZOLD DEREK J (Director, Pres. & Chief Exec. Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-09-30 Common Stock S 2831 $65.12 Disposed 293187 Direct
2021-09-30 Common Stock S 5469 $66.13 Disposed 287718 Direct
2021-09-30 Common Stock S 1700 $66.56 Disposed 286018 Direct
2021-09-30 Common Stock S 266 $65.09 Disposed 134528 Indirect
2021-09-30 Common Stock S 534 $66.24 Disposed 133994 Indirect
2021-09-30 Common Stock S 33 $66.64 Disposed 133961 Indirect
2021-09-30 Common Stock S 267 $65.09 Disposed 157367 Indirect
2021-09-30 Common Stock S 533 $66.24 Disposed 156834 Indirect
2021-09-30 Common Stock S 34 $66.64 Disposed 156800 Indirect
2021-09-30 Common Stock S 267 $65.09 Disposed 144765 Indirect
2021-09-30 Common Stock S 533 $66.24 Disposed 144232 Indirect
2021-09-30 Common Stock S 33 $66.64 Disposed 144199 Indirect

Footnotes

F1: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 11, 2020.

F2: This transaction was executed in multiple trades at prices ranging from $64.51 to $65.47, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $65.51 to $66.50, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $66.51 to $66.64, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: These transactions were made pursuant to a Rule 10b5-1 plan adopted by DJM Grantor Retained Annuity Trust No. 1, The Maetzold Descendants 2020 Trust, and the Derek Maetzold 2020 Irrevocable Trust on June 15, 2021.

F6: This transaction was executed in multiple trades at prices ranging from $64.51 to $65.43, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7: Held by DJM Grantor Retained Annuity Trust No. 1 of which the Reporting Person is the trustee and beneficiary.

F8: This transaction was executed in multiple trades at prices ranging from $65.58 to $66.57, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F9: Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries.

F10: Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries.